Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Disease Progression”

1,493 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,493 results

Large-scale testing (Phase 3)Looking for participantsNCT07389616
What this trial is testing

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT02099864
What this trial is testing

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
OHSU Knight Cancer Institute 36
Not applicableEnded earlyNCT00586404
What this trial is testing

The Study of Barrett's Esophagus: What Are the Factors of Progression

Who this might be right for
Barrett's EsophagusEsophageal Neoplasms
Midwest Biomedical Research Foundation 1,250
Not applicableNot Yet RecruitingNCT07154914
What this trial is testing

A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cance
Anhui Medical University 396
Testing effectiveness (Phase 2)UnknownNCT02452697
What this trial is testing

Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT

Who this might be right for
Myeloid MalignanciesLymphoid Malignancies
Cristina Gasparetto 36
Not applicableStudy completedNCT01500499
What this trial is testing

Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03753334
What this trial is testing

Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 39
Not applicableNot Yet RecruitingNCT07162324
What this trial is testing

A Multicenter, Prospective Study for Glioblastoma Patients

Who this might be right for
Glioblastoma
Larissa University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01008462
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more
Fred Hutchinson Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT00474188
What this trial is testing

Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene Corporation 26
Not applicableNot Yet RecruitingNCT06480721
What this trial is testing

FET-PET-Guided Management of Pseudoprogression in Glioblastoma

Who this might be right for
GlioblastomaRadionecrosis of Brain
Veerle Ruijters 144
Large-scale testing (Phase 3)UnknownNCT03100955
What this trial is testing

Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Progression Free Survival
Qingdao University 120
Not applicableLooking for participantsNCT06485076
What this trial is testing

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, RefractoryMultiple Myeloma Stage III+5 more
University Health Network, Toronto 144
Testing effectiveness (Phase 2)WithdrawnNCT02831491
What this trial is testing

Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)Ended earlyNCT01820364
What this trial is testing

LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma

Who this might be right for
Melanoma
Array BioPharma 15
Not applicableStudy completedNCT06558084
What this trial is testing

Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy

Who this might be right for
Toxicity, DrugProgression, Disease
Ain Shams University 64
Testing effectiveness (Phase 2)UnknownNCT02978547
What this trial is testing

The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma
British Columbia Cancer Agency 20
Large-scale testing (Phase 3)Ended earlyNCT00171925
What this trial is testing

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Who this might be right for
Multiple Myeloma Stage I
Novartis Pharmaceuticals 143
Large-scale testing (Phase 3)Looking for participantsNCT05549037
What this trial is testing

Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 210
Not applicableEnded earlyNCT00288275
What this trial is testing

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Precision Therapeutics 256
Load More Results